METASTATIC PROSTATE SMALL CELL CARCINOMA
Clinical trials for METASTATIC PROSTATE SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a three-drug cocktail outsmart resistant prostate cancer?
Disease control OngoingThis phase 2 trial is testing whether combining three drugs—ZEN-3694, enzalutamide, and pembrolizumab—can shrink tumors or lower PSA levels in men with metastatic castration-resistant prostate cancer that has worsened despite prior treatment. ZEN-3694 blocks a protein that fuels …
Matched conditions: METASTATIC PROSTATE SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Rahul Aggarwal • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New combo therapy aims to tame tough prostate cancer
Disease control OngoingThis phase 2 trial tests a multi-drug approach for men with aggressive variant prostate cancer that has spread. First, patients receive chemotherapy (cabazitaxel and carboplatin) plus an immunotherapy (cetrelimab). Then, they are randomly assigned to take either a PARP inhibitor …
Matched conditions: METASTATIC PROSTATE SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC